Stability Study of Morphine and Baclofen Solution in Polypropylene Syringes

Abstract Background The association of morphine and baclofen is used for the treatment of spasticity related pain. Moving these patients is sometimes difficult. In order to transport these syringes for pump refilling, it could be interesting to demonstrate the stability of the mixture, and so to be able to ensure the best transport conditions of syringes. Methods A stability indicating UPLC-DAD method was developed and validated according to the ICH guidelines. Two mixtures of morphine and baclofen – a low concentration mixture (morphine 1 mg/mL – baclofen 0.08 mg/mL) and a high concentration mixture (morphine 10 mg/mL – baclofen 1.6 mg/mL) stored in 5±3 °C and 25±2 °C were evaluated for seven days and compared to the initial observed concentrations. Results The stability of the low and high mixture is demonstrated for both storage conditions for seven days thanks to relative concentrations (95 % confidence intervals of the mean of 3 samples) systematically positioned between 95 % and 105 %. No degradation product was observed during the stability study. Conclusion This study shows the stability of a weakly concentrated mixture and a highly concentrated mixture of morphine and baclofen. Extrapolation of these data to an intermediate mixture may be considered. Further studies will support this hypothesis. This result will allow the transport of the preparation under optimal conditions. Advance preparations for intrathecal pump refills could also be feasible.

[1]  M. Saulino,et al.  The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines , 2017, Neuromodulation : journal of the International Neuromodulation Society.

[2]  D. Dupoiron,et al.  Rationale for Prospective Assays of Intrathecal Mixtures Including Morphine, Ropivacaine and Ziconotide: Prevention of Adverse Events and Feasibility in Clinical Practice. , 2015, Pain physician.

[3]  M. Saulino Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience. , 2012, European journal of physical and rehabilitation medicine.

[4]  S. Abram,et al.  Intrathecal Baclofen in Pain Management , 2003, Regional Anesthesia & Pain Medicine.

[5]  C. Inturrisi Clinical Pharmacology of Opioids for Pain , 2002, The Clinical journal of pain.

[6]  S. Hassenbusch,et al.  Evidence-based review of the literature on intrathecal delivery of pain medication. , 2000, Journal of pain and symptom management.

[7]  S. Abram,et al.  Intrathecal baclofen is analgesic in patients with chronic pain. , 2000, Anesthesiology.

[8]  P. Loubser,et al.  Effects of intrathecal baclofen on chronic spinal cord injury pain. , 1996, Journal of pain and symptom management.

[9]  L. Schaaf,et al.  Shelf‐lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient‐controlled analgesic devices , 1994, Journal of clinical pharmacy and therapeutics.

[10]  S. D'Luzansky,et al.  Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. , 1992, The Clinical journal of pain.

[11]  H. Bertalanffy,et al.  Combined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentiation pain. , 2002, Acta neurochirurgica. Supplement.

[12]  K. Takakura,et al.  A new approach to control central deafferentation pain: spinal intrathecal baclofen. , 1995, Stereotactic and functional neurosurgery.